These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22968478)

  • 1. Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer.
    Münch RC; Janicki H; Völker I; Rasbach A; Hallek M; Büning H; Buchholz CJ
    Mol Ther; 2013 Jan; 21(1):109-18. PubMed ID: 22968478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer.
    Muik A; Reul J; Friedel T; Muth A; Hartmann KP; Schneider IC; Münch RC; Buchholz CJ
    Biomaterials; 2017 Nov; 144():84-94. PubMed ID: 28825979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantially improved gene transfer to interneurons with second-generation glutamate receptor-targeted DART-AAV vectors.
    Günther DM; Kovacs R; Wildner F; Salivara A; Thalheimer FB; Fries P; Geiger JRP; Buchholz CJ
    J Neurosci Methods; 2023 Nov; 399():109981. PubMed ID: 37783350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.
    Ponnazhagan S; Mahendra G; Kumar S; Thompson JA; Castillas M
    J Virol; 2002 Dec; 76(24):12900-7. PubMed ID: 12438615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.
    Giles AR; Govindasamy L; Somanathan S; Wilson JM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the adeno-associated virus capsid in gene transfer.
    Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO
    Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand Coupling to the AAV Capsid for Cell-Specific Gene Transfer.
    Reul J; Muik A; Buchholz CJ
    Methods Mol Biol; 2019; 1950():35-50. PubMed ID: 30783967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
    Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
    Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV vector delivery to cells in culture.
    Smith A; Collaco R; Trempe JP
    Methods Mol Biol; 2004; 246():167-77. PubMed ID: 14970591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway.
    Davidoff AM; Ng CY; Zhou J; Spence Y; Nathwani AC
    Blood; 2003 Jul; 102(2):480-8. PubMed ID: 12637328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
    Grimm D; Kay MA
    Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
    Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
    J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery.
    Yu CY; Yuan Z; Cao Z; Wang B; Qiao C; Li J; Xiao X
    Gene Ther; 2009 Aug; 16(8):953-62. PubMed ID: 19474807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity.
    Mietzsch M; Hull JA; Makal VE; Jimenez Ybargollin A; Yu JC; McKissock K; Bennett A; Penzes J; Lins-Austin B; Yu Q; Chipman P; Bhattacharya N; Sousa D; Strugatsky D; Tijssen P; McKenna R; Agbandje-McKenna M
    J Virol; 2022 Jun; 96(11):e0033522. PubMed ID: 35532224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.